Targeting DNA to cells with basic fibroblast growth factor (FGF2).

The Journal of Biological Chemistry
B A SosnowskiA Baird

Abstract

Ligand-mediated targeting of DNA was validated by condensing a plasmid DNA encoding the beta-galactosidase (beta-gal) gene with a basic fibroblast growth factor (FGF2) that was first chemically conjugated to polylysine (K). The conditions that gave optimal binding of this FGF2 to DNA also generated the highest level of beta-gal expression when added to FGF2 target cells like COS-1, 3T3, baby hamster kidney (BHK), or endothelial cells. This beta-gal activity increased in a time- and dose-dependent manner and was dependent on the inclusion of FGF2 in the complex. FGF receptor specificity was demonstrated by competition of the complex with FGF2 and heparin, and by the failure of cytochrome c or histone H1 to mimic the gene-targeting effects of FGF2. The expression of beta-gal was also endosome dependent because chloroquine increased beta-gal expression 8-fold and endosome disruptive peptides increased expression of beta-gal 26-fold. Taken together these findings establish that DNA can be introduced into cells through the high affinity FGF receptor complex, and while its efficiency will require significant enhancements to achieve sustained and elevated transgene expression, the possibility that the technique could be used to delive...Continue Reading

References

May 29, 1979·Biochemistry·R W Wilson, V A Bloomfield
Mar 1, 1992·The Journal of Cell Biology·M T ShiehP G Spear
Apr 1, 1992·International Journal of Immunopharmacology·R J KreitmanI Pastan
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·W CasscellsA Baird
Mar 1, 1992·American Journal of Respiratory Cell and Molecular Biology·D T CurielR C Boucher
Oct 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C B SiegallI Pastan
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Aug 1, 1990·Analytical Biochemistry·J Alam, J L Cook
Jan 1, 1990·Progress in Growth Factor Research·D A Lappi, A Baird
Mar 10, 1989·Cell·J M GreveA McClelland
Oct 4, 1989·Journal of the National Cancer Institute·D FitzGerald, I Pastan
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J D FingerothD T Fearon
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·N V HudR Balhorn
Sep 1, 1994·Molecular Reproduction and Development·W L McKeehan, M Kan
Nov 1, 1993·The Journal of Clinical Investigation·T FerkolP B Davis
Jan 13, 1994·Biochemical Pharmacology·F AmalricN Quarto
Oct 1, 1993·American Journal of Respiratory Cell and Molecular Biology·C E HarrisD T Curiel
Feb 1, 1996·The Journal of Surgical Research·S G MattarA B Lumsden

❮ Previous
Next ❯

Citations

Jan 29, 2000·Biotechnology and Bioengineering·D V SchafferD A Lauffenburger
Jan 20, 2011·Pharmaceutical Research·Guoqin NiuJeffrey A Hughes
Nov 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maureen D BrownIjeoma F Uchegbu
Jun 15, 1999·Trends in Pharmacological Sciences·D L Ennist
Feb 19, 1999·Biochimica Et Biophysica Acta·D Y KwohD J Carlo
Sep 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H LeeT G Park
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haeshin LeeTae Gwan Park
Nov 10, 2000·Advanced Drug Delivery Reviews·R J Parkes, S L Hart
Dec 18, 2001·Advanced Drug Delivery Reviews·R KircheisE Wagner
Sep 3, 2002·Advanced Drug Delivery Reviews·Thomas MerdanThomas Kissel
Jun 6, 2000·Advanced Drug Delivery Reviews·W A Marasco, Dana Jones S
Jun 6, 2000·Advanced Drug Delivery Reviews·R J LevyJ Bonadio
Oct 18, 2001·International Journal of Pharmaceutics·M D BrownI F Uchegbu
Aug 24, 2000·Molecular Medicine Today·E H ChangK B Bouker
Aug 5, 2005·Gene Therapy·L K Medina-KauweS Hamm-Alvarez
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kathryn W RiddleDavid J Mooney
Jul 1, 1997·Human Gene Therapy·R W PaulR W Overell
May 24, 2007·Tissue Engineering·Arimichi OkazakiYasuhiko Tabata
Sep 23, 2000·Anti-cancer Drugs·K F PirolloE H Chang
May 4, 2001·Anti-cancer Drugs·A G Schatzlein
Aug 17, 1999·Annual Review of Nutrition·D B Jump, S D Clarke
May 26, 2001·Annual Review of Nutrition·P J Trotter
Jun 7, 2007·Journal of Biomaterials Science. Polymer Edition·D LiH Yu
Jan 1, 2005·American Journal of Respiratory Cell and Molecular Biology·Min QinRaj K Batra
Dec 1, 2000·Biochemical and Biophysical Research Communications·A Arís, A Villaverde
Jun 9, 2014·Human Molecular Genetics·Cynthia L NebenAmy E Merrill
Oct 16, 2004·Molecular and Cellular Neurosciences·Gunnar P H Dietz, Mathias Bähr
Oct 20, 2006·Journal of Drug Targeting·Takeshi TeradaMitsuru Hashida
Jan 10, 2002·Journal of Pharmaceutical Sciences·Ales ProkopJeffrey M Davidson
Jun 6, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Brenda F CanineArash Hatefi
Sep 18, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jun-ichiro Jo, Yasuhiko Tabata
Sep 3, 2013·Pediatric Pulmonology·Ye TianMalcolm Xing
Nov 3, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·M HaiderH Ghandehari

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.